Intercept Pharmaceuticals, Inc.
ICPT
ICPT was delisted on the 7th of November, 2023.
172 hedge funds and large institutions have $2.77B invested in Intercept Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 63 increasing their positions, 53 reducing their positions, and 30 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 53
3% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 30
1% less funds holding
Funds holding: 173 → 172 (-1)
10% less capital invested
Capital invested by funds: $3.09B → $2.77B (-$311M)
28% less call options, than puts
Call options by funds: $75.4M | Put options by funds: $105M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$172M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$26.5M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$21.1M |
| 4 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
+$16.3M |
| 5 |
State Street
Boston,
Massachusetts
|
+$15.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$62.5M |
| 2 |
Jennison Associates
New York
|
-$57.4M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$45.8M |
| 4 |
CCI
Columbus Circle Investors
|
-$15.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$12.8M |
ICPT Hedge Fund Activity: Q4 2015 in Review
172 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q4 2015, worth a combined $2.77B — down 10% from $3.09B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new ICPT positions and 30 closed out — a net gain of 1 holder — while 63 added to existing stakes and 53 trimmed.
The largest buyer was Ameriprise, adding an estimated $172M. The largest seller was Fred Alger Management, cutting an estimated $62.5M.
- 172 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q4 2015, down from 173 in Q3 2015.
- Funds reported $2.77B of Intercept Pharmaceuticals, Inc. stock for Q4 2015, down 10% quarter-over-quarter.
- 31 funds opened new Intercept Pharmaceuticals, Inc. positions in Q4 2015 and 30 closed out, a net change of +1 holder.
- The largest Intercept Pharmaceuticals, Inc. buyer in Q4 2015 was Ameriprise, an estimated $172M added.
- The largest Intercept Pharmaceuticals, Inc. seller in Q4 2015 was Fred Alger Management, an estimated $62.5M sold.
Based on aggregated 13F filings for Q4 2015.